Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results
March 24, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma
March 24, 2022 16:04 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces Appointment of Brenda Becker to Board of Directors
March 16, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
March 03, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces Multiple Presentations at the 2022 American Glaucoma Society Annual Meeting
March 02, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Participate in the Upcoming Citi Virtual Healthcare Conference
February 21, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma
February 17, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial Results
January 10, 2022 05:50 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences Receives FDA 510(k) Clearance of the TearCare® System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease
December 22, 2021 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
Sight Sciences to Participate in the Upcoming Piper Sandler Annual Healthcare Conference
November 18, 2021 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...